Home9966 • HKG
add
Alphamab Oncology
Previous close
$13.16
Day range
$12.95 - $13.87
Year range
$3.05 - $15.75
Market cap
12.97B HKD
Avg Volume
4.13M
P/E ratio
52.79
Dividend yield
-
Primary exchange
HKG
Financials
Income Statement
Revenue
Net income
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | 159.72M | 84.05% |
Operating expense | 143.77M | 25.47% |
Net income | 10.79M | 148.06% |
Net profit margin | 6.75 | 126.09% |
Earnings per share | — | — |
EBITDA | 15.42M | 155.44% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.64B | 12.92% |
Total assets | 2.36B | 10.13% |
Total liabilities | 503.95M | -1.81% |
Total equity | 1.85B | — |
Shares outstanding | 962.19M | — |
Price to book | 6.82 | — |
Return on assets | 0.03% | — |
Return on capital | 0.04% | — |
Cash Flow
Net change in cash
| (CNY) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | 10.79M | 148.06% |
Cash from operations | -923.00K | 95.99% |
Cash from investing | -182.89M | -1,063.97% |
Cash from financing | 41.00M | 41.17% |
Net change in cash | -143.28M | -628.64% |
Free cash flow | 4.04M | 133.73% |
About
CEO
Founded
2008
Website
Employees
484
